Vitality Watch

⚠ Evidence note: Nutrition evidence is dominated by observational data with heavy confounding; trial endpoints are mostly surrogates, not lifespan.

Mentioned 8× · first seen 09-sep-2026 · last seen 07-oct-2026

Dietary Flavonoids (Luteolin)

Current understanding

To be populated as evidence accumulates.

Evidence log

Open questions

Related

Contributing findings

rss preclinical
Novel Flavonoid Senotherapeutics Identified by Phenotypic Drug Discovery Reduce Senescence and Improve Multiple Markers of Healthspan
06-oct-2026 novelty 3 per-area 2 mentions
pubmed preclinical animal-model
A probioticconverts hesperidin to bioactive hesperetin and improves metabolic dysfunction in aging mice.
23-sep-2026 novelty 3 per-area 3 strengthens
pubmed preclinical
Hesperetin Attenuates Experimentally Induced Skeletal Muscle Dysfunction by Modulating Time-of-Day-Dependent Gene Expression and Mitochondrial Redox-Related Markers.
17-sep-2026 novelty 2 per-area 1 mentions
pubmed preclinical
Luteolin promotes healthy aging in adult females but shortens lifespan after embryonic exposure in.
20-aug-2026 novelty 3 per-area 2 introduces
pubmed preclinical
Luteolin and glycitein from Codonopsis pilosula ameliorate age-related locomotor decline in C. elegans via DAF-16-dependent but autophagy-divergent pathways.
13-aug-2026 novelty 2 per-area 2 strengthens
pubmed preclinical
Sea buckthorn flavonoid IGRh and its metabolites delay Caenorhabditis elegans aging via SIR-2.1/DAF-16-mediated IIS and autophagy-lysosomal pathways.
14-jul-2026 novelty 2 per-area 2 strengthens
pubmed preclinical
Cyanidin chloride activates mitophagy to delay aging via PINK1/parkin pathway.
13-jun-2026 novelty 3 per-area 2 mentions
pubmed preclinical
Osteogenic promotion by naringin through the PI3K/AKT/mTOR pathway-mediated activation of autophagy and inhibition of apoptosis.
02-jun-2026 novelty 2 per-area 2 mentions

build build 880 · 2bcef25 · 2026-11-18